Tables at a glance

Table 1

Table 2

Table 3

Table 4

Table 5

Table 6

Table 7

Table 8

Table 9

Table 11

Table 12

Table 13

Figures at a glance

Comments

Figure 1

Comments

Figure 2

Comments

Figure 3

Comments

Figure 4

Comments

Figure 5

Comments

Figure 6

Comments

Figure 7

Table 1

Age (in years)	Frequency	Percentage (%)
19-30	18	11.3
31-40	35	22.0
41-50	69	43.4
51-60	37	23.3
Total	159	100

Table 1: Age distribution of participants (N=159)

Table 2

Gender	Frequency	Percentage (%)
Male	86	54.1
Female	73	45.9
Total	159	100

Table 2: Gender distribution of participants (N=159)

Table 3

Residence	Frequency	Percentage (%)
Urban	73	45.9
Rural	86	54.1
Total	159	100

Table 3: Residence distribution of participants (N=159)

Table 4

Body Mass Index	Frequency	Percentage (%)
Underweight	20	12.6
Normal	57	35.9
Overweight	28	17.6
Obese	54	33.9
Total	159	100

Table 4: Body Mass Index distribution of participants (N=159)

Table 5

Family history of CVD	Frequency	Percentage (%)
Yes	23	14.5
No	136	85.5
Total	159	100

Table 5: Family history of CVD distribution among participants (N=159)

Table 6

Diabetes	Frequency	Percentage (%)
Yes	7	4.4
No	152	95.6
Total	159	100

Table 6: Diabetes distribution among participants (N=159)

Table 7

Hypertension	Frequency	Percentage (%)
Yes	15	9.4
No	144	90.6
Total	159	100

Table 7: Hypertension distribution among participants (N=159)

Table 8

ART duration (in years)	Frequency	Percentage (%)
<5	39	24.5
5-10	112	70.4
>10	8	5.1
Total	159	100

Table 8: ART duration distribution

Table 9

Variables	Mean	Median	Percentiles
Variables	Mean	Median	25	50	75
Age (in years)	43.7±9.9	45	38	45	50
2 BMI (kg/m )	23.5 ± 4.6	23.2	20.0	23.2	25.9
Systolic Blood Pressure (mmHg)	118.2 ±12.4	120	110	120	130
3 CD4 at start of ART (cells/mm )	379.1±239.5	367	189	367	473
3 CD4 at 6 months (cells/mm )	451.4±254.5	410	245	410	605
3 CD4 at 12 months (cells/mm )	510.3±263.2	458	327	458	660
3 CD4 at latest (cells/mm )	570.2±219.6	556	420	556	701
Serum albumin (mg/dl)	4.2±0.6	4.2	4	4.2	4.5
HDL (mg/dl)	43.9±13.6	42	37.3	42	48
Total cholesterol (mg/dl)	177.4±40.9	172	150	172	197
RBS	118.3±40.9	108	96	108	132
Serum creatinine (mg/dl)	0.9±0.2	0.98	0.84	0.98	1.1
Haemoglobin (gm%)	12.3±1.9	12.4	11	12.4	13.5
AST (IU/L)	29.0±15.3	24	20	24	34
ALT (IU/L)	31.9±19.3	26	21	26	36

Table 9: Descriptive statistics of participants (N=159)

Table 10: Serum albumin distribution among participants (N=159)

Table 11

D:A:D CVD risk 5 years	Frequency	Percentage (%)
Low	9	5.7
Moderate	71	44.6
High	33	20.8
Very High	46	28.9
Total	159	100

Table 11: D:A:D CVD risk at 5 years distribution among participants (N=159)

Table 12

D:A:D CVD risk at 5 years	Serum Albumin		P value*
D:A:D CVD risk at 5 years	Lown (%)	Normal n (%)	P value*
Low	1 (2.7)	8 (6.6)	0.30
Moderate	15 (40.5)	56 (45.9)
High	6 (16.2)	27 (22.1)
Very High	15 (40.5)	31 (25.4)
Total	37 (100.0)	122 (100.0)

Table 12: D:A:D CVD risk at 5 years distribution among participants (N=159)

Table 13

		D:A:D CVD risk 5 years
Serum albumin	Pearson Correlation	-0.005
	P value	0.95
	N	159
Correlation is non-significant (p value = 0.95)

Table 13: Correlation between Serum albumin and D:A:D CVD risk at 5 years

Table 14

D:A:D CVD risk at 5 years	Serum Albumin		P value*
D:A:D CVD risk at 5 years	Mean	SD	P value*
Low	4.19	0.25	0.04
Moderate	4.18	0.54
High	4.17	0.64
Very High	4.13	0.59

Table 14: Association of Mean Serum albumin and D:A:D CVD risk at 5 years among participants

FIGURE 1

Figure 1: Age distribution of participants (N=159)

FIGURE 2

Figure 2: Body Mass Index distribution of participants (N=159)

FIGURE 3

Figure 3: Diabetes distribution among participants (N=159)

FIGURE 4

Figure 4: Hypertension distribution among participants (N=159)

FIGURE 5

Figure 5: ART duration distribution

FIGURE 6

Figure 6: Serum albumin distribution among participants (N=159)

FIGURE 7

Figure 7: D:A:D CVD risk at 5 years distribution among participants (N=159)